236 related articles for article (PubMed ID: 32363121)
1. B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells.
Lu H; Shi T; Wang M; Li X; Gu Y; Zhang X; Zhang G; Chen W
Oncoimmunology; 2020; 9(1):1748991. PubMed ID: 32363121
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W
Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798
[TBL] [Abstract][Full Text] [Related]
3. Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression.
Li X; Lu H; Gu Y; Zhang X; Zhang G; Shi T; Chen W
Exp Cell Res; 2020 Jan; 386(1):111719. PubMed ID: 31726050
[TBL] [Abstract][Full Text] [Related]
4. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K; Chen L
Nat Immunol; 2001 Mar; 2(3):269-74. PubMed ID: 11224528
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer.
Sureshbabu SK; Chaukar D; Chiplunkar SV
Clin Exp Immunol; 2020 Jul; 201(1):40-57. PubMed ID: 32255193
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 on breast cancer cell MCF7 inhibits IFN-γ release from tumour-infiltrating T cells.
Shao L; Yu Q; Xia R; Zhang J; Gu S; Yu D; Zhuang Z
Pathol Res Pract; 2021 Aug; 224():153461. PubMed ID: 34265738
[TBL] [Abstract][Full Text] [Related]
7. HDAC is indispensable for IFN-γ-induced B7-H1 expression in gastric cancer.
Deng R; Zhang P; Liu W; Zeng X; Ma X; Shi L; Wang T; Yin Y; Chang W; Zhang P; Wang G; Tao K
Clin Epigenetics; 2018 Dec; 10(1):153. PubMed ID: 30537988
[TBL] [Abstract][Full Text] [Related]
8. Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity.
Xu Y; Xiao Y; Luo C; Liu Q; Wei A; Yang Y; Zhao L; Wang Y
Int Immunopharmacol; 2020 Jul; 84():106584. PubMed ID: 32422527
[TBL] [Abstract][Full Text] [Related]
9. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
10. T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting.
Sun X; Yu Y; Ma L; Xue X; Gao Z; Ma J; Zhang M
Invest New Drugs; 2020 Jun; 38(3):722-732. PubMed ID: 31267380
[TBL] [Abstract][Full Text] [Related]
11. Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo.
Ma J; Shang T; Ma P; Sun X; Zhao J; Sun X; Zhang M
Invest New Drugs; 2019 Oct; 37(5):1036-1043. PubMed ID: 30706335
[TBL] [Abstract][Full Text] [Related]
12. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration.
Li L; Nian S; Liu Q; Zhang B; Jimu W; Li C; Huang Z; Hu Q; Huang Y; Yuan Q
Int Immunopharmacol; 2024 May; 132():111926. PubMed ID: 38552297
[TBL] [Abstract][Full Text] [Related]
13. IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling.
Xiong HY; Ma TT; Wu BT; Lin Y; Tu ZG
Asian Pac J Cancer Prev; 2014; 15(14):5767-72. PubMed ID: 25081699
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
15. Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.
Accardo-Palumbo A; Giardina AR; Ciccia F; Ferrante A; Principato A; Impastato R; Giardina E; Triolo G
Arthritis Res Ther; 2010; 12(3):R109. PubMed ID: 20525258
[TBL] [Abstract][Full Text] [Related]
16.
Wu D; Wu P; Wu X; Ye J; Wang Z; Zhao S; Ni C; Hu G; Xu J; Han Y; Zhang T; Qiu F; Yan J; Huang J
Oncoimmunology; 2015 Mar; 4(3):e992749. PubMed ID: 25949914
[TBL] [Abstract][Full Text] [Related]
17. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.
Liu J; Hamrouni A; Wolowiec D; Coiteux V; Kuliczkowski K; Hetuin D; Saudemont A; Quesnel B
Blood; 2007 Jul; 110(1):296-304. PubMed ID: 17363736
[TBL] [Abstract][Full Text] [Related]
18. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
[TBL] [Abstract][Full Text] [Related]
19. An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
Lupu CM; Eisenbach C; Kuefner MA; Schmidt J; Lupu AD; Stremmel W; Encke J
J Gastrointest Surg; 2006 May; 10(5):635-45. PubMed ID: 16713537
[TBL] [Abstract][Full Text] [Related]
20. Soluble mouse B7-H3 down-regulates dendritic cell stimulatory capacity to allogenic T cell proliferation and production of IL-2 and IFN-gamma.
Xu J; Huang B; Xiong P; Feng W; Xu Y; Fang M; Zheng F; Gong F
Cell Mol Immunol; 2006 Jun; 3(3):235-40. PubMed ID: 16893505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
